Skip to main content
. 2021 Jan 19;3(2):100232. doi: 10.1016/j.jhepr.2021.100232

Fig. 1.

Fig. 1

Age-standardised incidence and incidence-based mortality.

(A) Primary liver cancer; (B) hepatocellular carcinoma; (C) intrahepatic cholangiocarcinoma; (D) other and unspecified liver tumours. Estimates from 3-year rolling cohorts. ASR, age-standardised incidence rate per 100,000.